Brief: Medicalgorithmics Says DeepRhythm Platform Approved By FDA For U.S. Markets
24/06/2024 06:18
June 24 (Reuters) - Medicalgorithmics SA MDG.WA :
* FDA GREENLIGHTS COMPANY'S DEEPRHYTHM PLATFORM FOR US MARKETS
* FDA'S APPROVAL ALLOWS FOR COMMERCIALISATION OF PLATFORM
Source text for Workspace: urn:newsml:reuters.com:*:nEM7Xb5N8a
Further company coverage: MDG.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Medicalgorithmics SA
See all newsBrief: Medicalgorithmics Signs Deal With Accyourate Group For Services Based On DeepRhythm Platform And DeepRhythmAI Algorithms
Brief: Medicalgorithmics Signs LOI To Develop Robotic System For Heart Defect Treatment
Brief: Medicalgorithmics Signs LoI With A Medtech Holding On Potential Strategic Investment
Brief: Medicalgorithmics SA - Receives Additional Kardiobeat.Ai Device Order Worth $500,000 From Canadian Partner
Brief: Medicalgorithmics Signs Annex To Loan Agreement With Biofund